UAN CVR PARTNERS, LP
Agricultural Chemicals · NYSE · SEC CIK 1425292 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.3%
TTM net income YoY-16.4%
TTM EPS YoY-16.4%
Revenue 3-yr CAGR-4.3%
Net income 3-yr CAGR-25.5%
Margins
Gross margin26.5%
Operating margin20.6%
Net margin16.1%
FCF margin22.6%
EBITDA margin34.0%
Returns
ROE—
ROA10.2%
ROIC (approx.)—
Asset turnover0.63x
Leverage & solvency
Liabilities / assets—
Debt / equity—
Current ratio1.65x
Interest coverage—
Cash quality & payout
Operating cash flow / net income2.23x
Accruals ratio-12.5%
Payout ratio—
Capex / revenue13.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $606.04M | $525.32M |
| Cost of revenue | $442.67M | $406.46M |
| Gross profit | $163.37M | $118.86M |
| SG&A expense | $33.59M | $28.41M |
| Operating income | $128.66M | $90.35M |
| Pretax income | $98.64M | $60.98M |
| Income tax | -$23,000 | $77,000 |
| Net income | $98.66M | $60.90M |
| EBITDA | $210.53M | $178.45M |
| EPS (basic) | 9.33 | 5.76 |
| EPS (diluted) | 9.33 | 5.76 |
| Weighted avg. shares (diluted) | 10.57M | 10.57M |
| Balance sheet | ||
| Cash & equivalents | $69.24M | $90.86M |
| Receivables | $58.96M | $65.22M |
| Inventory | $82.68M | $75.58M |
| Current assets | $213.87M | $233.54M |
| PP&E, net | $711.82M | $735.59M |
| Total assets | $969.46M | $1.02B |
| Current liabilities | $96.77M | $111.35M |
| Short-term debt | $778,000 | $877,000 |
| Long-term debt | $569.07M | $567.97M |
| Total debt | $569.85M | $568.85M |
| Shareholders' equity | — | — |
| Net debt | $500.60M | $477.99M |
| Cash flow statement | ||
| Operating cash flow | $149.64M | $150.54M |
| Capital expenditure | $50.80M | $37.07M |
| Free cash flow | $98.84M | $113.47M |
| Investing cash flow | -$44.09M | -$31.89M |
| Financing cash flow | -$127.17M | -$73.07M |
| Depreciation & amortization | $81.87M | $88.10M |
| Stock-based compensation | $9.80M | $4.90M |
| Share buybacks | — | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.